Economic Impact of Cost-Containment Strategies in Third Party Programmes in the US (Part I)1
- 1 August 1993
- journal article
- Published by Springer Nature in PharmacoEconomics
- Vol. 4 (2) , 92-103
- https://doi.org/10.2165/00019053-199304020-00004
Abstract
The rising cost of healthcare has strained the resources of governments, private third parties and individuals with responsibility to pay for it. Various strategies have been used in an attempt to...Keywords
This publication has 16 references indexed in Scilit:
- Prescription Cost SharingPharmacoEconomics, 1992
- Payment Restrictions for Prescription Drugs under MedicaidPharmacoEconomics, 1992
- A Comparative Study of Current Medicaid Prescription Reimbursement (MACtEAC) with Prescription Reimbursement Based on a Competitive MarketJournal of Pharmaceutical Marketing & Management, 1988
- Use of medical care in the Rand Health Insurance Experiment. Diagnosis- and service-specific analyses in a randomized controlled trial.1986
- The differential impact of copayment on drug use in a Medicaid population.1985
- The demand for prescription drugs as a function of cost-sharingSocial Science & Medicine, 1985
- Some Interim Results from a Controlled Trial of Cost Sharing in Health InsuranceNew England Journal of Medicine, 1981
- Copayment for pharmaceutical services in a Medicaid program.1980
- Penny-Wise and Found-Foolish: Another Look at the DataMedical Care, 1976
- Comment on 'Copayments for Ambulatory Care: Penny-Wise and Pound-Foolish'Medical Care, 1976